Bacteremia in Critically Ill Patients with SARS-CoV 2 Infection

Background: Since December 2019, the COVID-19 pandemic has caused dead of 1 million people, from these critically ill patients have an increased risk bacteremia. Material and Methods: This observational, retrospective, single-center study included 129 with a We studied clinical characteristics, comorbidities, hospital intensive care unit length stay, days on invasive mechanical ventilation, maximum dose norepinephrine mortality. Results: From were reported 17 (13.2%) 35.3% cataloged as primary The source secondary bacteremia was ventilator associated pneumonia in 81.8%, central line-associated blood stream infection 18.1% urinary catheter 9%. bacteremia, had hospitalization stay 23 Vs. 20.5 without (p=0.19); 18 13.5 ICU (p=0.061); 15 Vs 11 IMV (p=0.053) 0.28 0.11 mcg/kg/min (p=0.02). 14.8% mortality vs. 12.7% odds ratio 0.87 (p=0.75). Conclusion: Critically tend to increase no change